Obermeyer Wealth Partners Has $39.95 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Obermeyer Wealth Partners cut its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 78,976 shares of the healthcare conglomerate's stock after selling 6,693 shares during the period. UnitedHealth Group comprises about 2.1% of Obermeyer Wealth Partners' portfolio, making the stock its 15th largest position. Obermeyer Wealth Partners' holdings in UnitedHealth Group were worth $39,951,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $28,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.6%

Shares of UNH stock opened at $378.42 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $337.70 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $343.28 billion, a PE ratio of 24.41, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The business's fifty day moving average is $486.06 and its 200 day moving average is $520.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the business earned $6.91 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.22%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on UNH shares. Mizuho increased their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial reduced their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research note on Monday, April 21st. Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, Raymond James reissued a "strong-buy" rating and issued a $540.00 price objective (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Four equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.